Abstract
During the last decades, the technical improvement in clinical, abdominal radiological, and endoscopic imaging techniques leads to an increased detection and finest characterization of previously mostly underdiagnosed/misdiagnosed pathological entities such as pancreatic cystic neoplasms. This kind of lesions displays an overall prevalence up to 20 % and a biological spectrum that nuances from benign to malignant behavior.
Particularly in the setting of malignant disease, there is lack of evidences about possible neoadjuvant and adjuvant treatments that could be complementary to surgery. In this book chapter, we will try to provide an as much as possible complete, evidence-based overview on all the possible medical treatments of the pancreatic cystic tumors considering both possible neoadjuvant and adjuvant treatments in the setting of IPMNs and cystic lesion other than IPMNs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Del Chiaro M, et al. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis. 2013;45(9):703–11.
Chin JY, Pitman MB, Hong TS. Intraductal papillary mucinous neoplasm: clinical surveillance and management decisions. Semin Radiat Oncol. 2014;24(2):77–84.
Wasif N, et al. Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes. Cancer. 2010;116(14):3369–77.
Turrini O, et al. Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy. HPB (Oxford). 2010;12(7):447–55.
Swartz MJ, et al. Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas. Int J Radiat Oncol Biol Phys. 2010;76(3):839–44.
Alexander BM, et al. Intraductal papillary mucinous adenocarcinoma of the pancreas: clinical outcomes, prognostic factors, and the role of adjuvant therapy. Gastrointest Cancer Res. 2011;4(4):116–21.
Caponi S, et al. Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms. Eur J Surg Oncol. 2013;39(4):396–403.
Worni M, et al. Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry. Ann Surg Oncol. 2012;19(4):1316–23.
Otsuka T, et al. Gemcitabine in patients with intraductal papillary mucinous neoplasm with an associated invasive carcinoma of the pancreas. Pancreas. 2013;42(5):889–92.
Arjona-Sanchez A, et al. Long-term survival with peritoneal mucinous carcinomatosis from intraductal mucinous papillary pancreatic carcinoma treated with complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Int J Hyperthermia. 2014;30(6):408–11.
Valente R, et al. Simultaneous intraductal papillary neoplasms of the bile duct and pancreas treated with chemoradiotherapy. World J Gastrointest Oncol. 2012;4(2):22–5.
Dovigo AG, et al. Liver transplantation as treatment in a massive metastasis from Gruber-Frantz pancreatic tumor: a case report. Transplant Proc. 2011;43(6):2272–3.
Sumida W, et al. Liver transplantation for multiple liver metastases from solid pseudopapillary tumor of the pancreas. J Pediatr Surg. 2007;42(12):e27–31.
Ji S, et al. Management of a malignant case of solid pseudopapillary tumor of pancreas: a case report and literature review. Pancreas. 2012;41(8):1336–40.
Romics Jr L, et al. Solid pseudopapillary neoplasm of the pancreas--proposed algorithms for diagnosis and surgical treatment. Langenbecks Arch Surg. 2010;395(6):747–55.
Kanter J, Wilson DB, Strasberg S. Downsizing to resectability of a large solid and cystic papillary tumor of the pancreas by single-agent chemotherapy. J Pediatr Surg. 2009;44(10):e23–5.
Maffuz A, et al. Preoperative gemcitabine for unresectable, solid pseudopapillary tumour of the pancreas. Lancet Oncol. 2005;6(3):185–6.
Zauls JA, Dragun AE, Sharma AK. Intensity-modulated radiation therapy for unresectable solid pseudopapillary tumor of the pancreas. Am J Clin Oncol. 2006;29(6):639–40.
Krug S, et al. Successful selective internal radiotherapy (SIRT) in a patient with a malignant solid pseudopapillary pancreatic neoplasm (SPN). Pancreatology. 2012;12(5):423–7.
Shimada K, et al. A case of advanced mucinous cystadenocarcinoma of the pancreas with peritoneal dissemination responding to gemcitabine. Gan To Kagaku Ryoho. 2009;36(6):995–8.
Obayashi K, et al. Remarkable effect of gemcitabine-oxaliplatin (GEMOX) therapy in a patient with advanced metastatic mucinous cystic neoplasm of the pancreas. Gan To Kagaku Ryoho. 2008;35(11):1915–7.
Di Marco M, et al. Preoperative gemcitabine and oxaliplatin in a patient with ovarian metastasis from pancreatic cystadenocarcinoma. Case Rep Gastroenterol. 2012;6(2):530–7.
Bjork Werner J, et al. Mucinous cystadenocarcinoma of the pancreas - outcome following different modes of treatment. Ann Gastroenterol. 2011;24(3):213–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Valente, R., Löhr, JM. (2016). Oncological Treatment of Cystic Tumors of the Pancreas. In: Del Chiaro, M., Haas, S., Schulick, R. (eds) Cystic Tumors of the Pancreas. Springer, Cham. https://doi.org/10.1007/978-3-319-31882-0_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-31882-0_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-31880-6
Online ISBN: 978-3-319-31882-0
eBook Packages: MedicineMedicine (R0)